Literature DB >> 139964

Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder.

C Fossard, R A Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 139964      PMCID： PMC1606027          DOI： 10.1136/bmj.1.6065.883

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

2.  Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome.

Authors:  S Kusakawa; D C Heiner
Journal:  Pediatr Res       Date:  1976-02       Impact factor: 3.756

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124
  3 in total
  12 in total

Review 1.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

2.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

3.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

4.  Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease)

Authors:  A M Weindling; R J Levinsky; W C Marshall; J Hood
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

5.  Circulating immune complex in the mucocutaneous lymph node syndrome.

Authors:  A Furuse; I Matsuda
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

6.  Kawasaki disease in Canterbury.

Authors:  G J Morgan; M A Lynch
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

7.  Mucocutaneous lymph node syndrome with necrotic pharyngitis.

Authors:  L Brion; M Courtoy; D Bachelart; H Szliwowski; M Dickstein; M Heenen; M Tondeur
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

8.  Complement and protease inhibitors in the mucocutaneous lymph node syndrome.

Authors:  C H Rieger; T Kawasaki; Y Yanase; U Pollack
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

9.  Kawasaki disease: monitoring of circulating immune complexes.

Authors:  E Salo; R Kekomäki; P Pelkonen; O Ruuskanen; M Viander; O Wagner
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

10.  Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.

Authors:  M Levin; P C Holland; T J Nokes; V Novelli; M Mola; R J Levinsky; M J Dillon; T M Barratt; W C Marshall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.